In our present clinical study, concentrations of plasma Hsp90α in breast cancer patients gradually increased as their clinical stages of regional lymph nodes advanced, indicating the involvement of eHsp90α in the lymph node metastasis. Here, HSP90AA1 is linked to breast cancer.